Searched for
GANORKAR
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Obesity treatment drugs to be new growth engine for pharma industry: Sun PharmaIndia, known for its generic drug industry, is rapidly transforming into a major hub for global weight management industry, amid rapid incr...
- Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....
- Kirti Ganorkar: Why the veteran insider is the right dose for Sun PharmaKirti Ganorkar, a long-time Sun Pharma veteran, will take over as Managing Director from September 1, succeeding founder Dilip Shanghvi, wh...
- Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the BoardSun Pharmaceutical Industries has appointed Kirti Ganorkar as Managing Director, succeeding Dilip Shanghvi, effective September 1. Shanghvi...
- TATA AIG General Insurance Company appoints Amit Ganorkar as MD and CEOAmit Ganorkar is the new managing director and CEO of TATA AIG General Insurance Company, starting January 1, 2025, succeeding Neelesh Garg...
- Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...
- Sun Pharma to market Zydus' novel anti-CKD drug desidustat in India“The addition of RYTSTAT further strengthens our nephrology portfolio in India," said Kirti Ganorkar, CEO - India Business, Sun Pharma.
- Sun Pharma launches novel therapy for dry eye disease in IndiaDED is caused when the quantity or quality of tears fails to keep the surface of the eye properly lubricated, and associated with symptoms ...
- Sun Pharma plans to focus on market share, sales in bid to outdo rivalsAs part of the strategy to stay ahead of its rivals in the highly fragmented domestic formulation business, Sun Pharma has embarked on majo...
- Sun Pharma to expand field force in India by 10 pc this fiscal"The field force expansion done in FY21 has met with good success and considering the current market conditions, we will be undertaking a f...
- Sun Pharma enters licensing pact with Lundbeck to launch novel anti-depressant pill in IndiaVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults.
- Pharma, healthcare industry looks to sustain momentum in 2022Listing out difficulties for the domestic pharma industry, Sun Pharma CEO (India Business) Kirti Ganorkar said that currency fluctuations, ...
- Sun Pharma says gearing up to launch COVID drug molnupiravirThe company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...
- BJP worker's killing: Cong leader gets anticipatory bailA Maharashtra court has granted anticipatory bail to Congress leader Hidayat Patel in connection with the killing of a BJP worker in Akola ...
- Sun Pharma, NIV join hands to fight zika, chikungunya, dengueUnder the agreement, Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems, the c...
- ICGEB, Sun Pharma tie-up to develop novel dengue drugICGEB and Sun Pharma will develop the drug, known as Cipa, following a registration process that consists of trials and studies that meet b...
Load More
